Certara outlines flat to 4% 2026 revenue growth as new CEO signals operational overhaul and $10M cost avoidance
Source: SeekingAlpha
2026-02-26 13:38:58 ET
More on Certara
- Certara, Inc. (CERT) Q4 2025 Earnings Call Transcript
- Certara, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Certara Non-GAAP EPS of $0.09 misses by $0.01, revenue of $103.6M beats by $0.37M
- Certara Q4 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Certara
Read the full article on Seeking Alpha
For further details see:
Certara outlines flat to 4% 2026 revenue growth as new CEO signals operational overhaul and $10M cost avoidance
Certara Inc.
NASDAQ: CERT
CERT Trading
0.0% G/L:
$6.895 Last:
537,093 Volume:
$6.79 Open:
CERT Latest News
March 03, 2026 08:00:00 am
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
February 26, 2026 06:00:00 am
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance
CERT Stock Data
$1,117,302,670
119,709,863
1.48%
94
N/A
Healthcare Providers & Services
Healthcare
US
Radnor
